<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368365">
  <stage>Registered</stage>
  <submitdate>14/04/2015</submitdate>
  <approvaldate>16/06/2015</approvaldate>
  <actrnumber>ACTRN12615000626561</actrnumber>
  <trial_identification>
    <studytitle>Haemodynamic and Respiratory Effects of Volume-Controlled Versus Pressure-Controlled Ventilation During Gynecologic Surgery</studytitle>
    <scientifictitle>Haemodynamic and Respiratory Effects of Volume-Controlled Versus Pressure-Controlled Ventilation During Gynecologic Laparoscopic Surgery in Steep Trendelenburg Position </scientifictitle>
    <utrn>U1111-1169-2536</utrn>
    <trialacronym />
    <secondaryid>NONE</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>ENDOMETRIUM CARCINOMA</healthcondition>
    <healthcondition>CERVIX CARCINOMA</healthcondition>
    <healthcondition>MYOMA UTERI</healthcondition>
    <healthcondition>UTERINE PROLAPSUS</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Mechanical ventilation mode:
PCV is an alternative mode of ventilation to VCV that is widely used in patients with elevated intraabdominal pressure and it has been shown to improve arterial oxygenation and decrease the peak airway pressure because of its decelerating inspiratory flow. 

Mechanical ventilation will be administered continuously from induction of anesthesia until extubation. In the pressure-controlled group, the peak airway pressure not exceeding 35 cmH2O will be set to provide a tidal volume of 8 ml/kg, with and I:E ratio of 1:1,5. The respiratory rate will be adjusted to obtain an end-tidal CO2 of 35-40 cmH2O to be started with a respiratory rate of 12/min.</interventions>
    <comparator>VCV is considered as a control
Mechanical ventilation will be administered continuously from induction of anesthesia until extubation.
In the volume controlled group, the ventilation will be started with a tidal volume of 8 ml/kg and the initial tidal volume will be increased by 1 mL/kg every 5 minutes until 12 mL/kg. Respiratory rate will initially be set to 12/min with an I:E ratio of 1:1,5 and will be increased by 2/min every 5 min till 20/min to maintain an end-tidal CO2 between 35-40 mmHg.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Mean peak airway pressure
Lower peak airway pressure levels are expected on respiratory monitor</outcome>
      <timepoint>Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)
</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Cardiac output by using picco</outcome>
      <timepoint>Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Arterial carbondioxide level by arterial blood gas analysis</outcome>
      <timepoint>Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA physical status I-II
Robotic gynaecologic surgery patients</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Valvular heart disease
Abnormal regional wall contraction in echocardiography
Pericardial disease
Dilated cardiomyopathy
Left atrial dialtation
Left ventricular dilatation
Obstructive/restrictive lung disease
Body mass index&gt;30
Eosophageal disease/dysphagia 
Blood loss leading more than %10 decrease in MAP</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The patients are going to be randomly allocated to one of two groups using central randomisation by phone</concealment>
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>ISTANBUL</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Medipol University</primarysponsorname>
    <primarysponsoraddress>TEM Avrupa Otoyolu Goztepe Cikisi No:1
34214,
Bagcilar
Istanbul
Turkey</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Medipol Mega Hastaneler Kompleksi</sponsorname>
      <sponsoraddress>TEM Avrupa Otoyolu Goztepe Cikisi No:1
34214,
Bagcilar
Istanbul
Turkey</sponsoraddress>
      <sponsorcountry>Turkey</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this stydy is to compare the effects of volume-controlled and pressure-controlled ventilation on cardiac output changes in patients undergoing robotic assisted gynecologic surgery in steep Trendelenburg position.
Hypothesis: PCV may be a more effective method for maintaining more stable haemodynamics.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Istanbul Medipol University Interventional Clinical Trials Ethics Commitee</ethicname>
      <ethicaddress>Kavacik Mahallesi
Ekinciler Caddesi No:19 
34810
Beykoz
Istanbul
Turkey</ethicaddress>
      <ethicapprovaldate>30/12/2014</ethicapprovaldate>
      <hrec>10840098-378</hrec>
      <ethicsubmitdate>26/12/2014</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>NESRIN AHU ASLAN</name>
      <address>Gokturk Merkez Mahallesi
1. Kartepe Sokak
Yeshill Sitesi F Blok D:2
34077
Eyup
Istanbul
Turkey</address>
      <phone>+90 532 3965678</phone>
      <fax />
      <email>DRAHUASLAN@YAHOO.COM</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>NESRIN AHU ASLAN</name>
      <address>Gokturk Merkez Mahallesi
1. Kartepe Sokak
Yeshill Sitesi F Blok D:2
34077
Eyup
Istanbul
Turkey</address>
      <phone>+90 532 3965678</phone>
      <fax />
      <email>DRAHUASLAN@YAHOO.COM</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>NESRIN AHU ASLAN</name>
      <address>Gokturk Merkez Mahallesi
1. Kartepe Sokak
Yeshill Sitesi F Blok D:2
34077
Eyup
Istanbul
Turkey</address>
      <phone>+90 532 3965678</phone>
      <fax />
      <email>DRAHUASLAN@YAHOO.COM</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>NESRIN AHU ASLAN</name>
      <address>GOKTURK MERKEZ MAHALLESI
1.KARTEPE SOKAK
YESHILL SITESI F BLOK D:2
EYUP/ISTANBUL</address>
      <phone>+90 532 3965678</phone>
      <fax />
      <email>DRAHUASLAN@YAHOO.COM</email>
      <country>Turkey</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>